SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Biotechnology

Healthcare
$29.68 +2.49%

+$0.45 today

Market cap
$993.14M
Beta
-0.34
P/E (TTM)
-14.1
EPS (TTM)
-$1.32
52W Low $17.06High $32.44

Volume 0.10M

Average 0.09M

SGP Interest Income

Income earned on cash, deposits, and investments held by the company.

SpyGlass Pharma, Inc. Common StockNASDAQ: SGP

Interest Income · Q1 FY2026 · quarter ended Mar 2026

Interest income of $1.59M in Q1 FY2026

Q1 FY2026 interest income was $1.59M.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$1.59M+48.3% QoQ
Last fiscal yearDec 2025
$3.11M— YoY
Interest Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Interest Income history

USD · from the income statement

Latest · FY2025
3.11M USD
Year-over-year change
—

Interest Income vs competitors

How SGP compares with its peers on the latest reported figures

  • Peers report in different currencies, so interest income is compared through growth and share of revenue rather than absolute size.
SGP Competitors
Interest Income for SGP and competitors
Company Period LTM YoY 3-year CAGR% of revenue
OCULOcular Therapeutix, Inc.LTM Mar 2026$20.58M USD+1.9%+184.4%39.5%
BLCOBausch + Lomb CorporationLTM Jun 2026$14M USD-6.7%+26.0%0.3%
EYPTEyePoint Pharmaceuticals, Inc.LTM Mar 2026$10.45M USD-28.9%+76.7%137.3%
GKOSGlaukos CorporationLTM Jun 2026$9.77M USD-9.9%+65.2%1.6%
RXSTRxSight, Inc.LTM Mar 2026$8.78M USD-15.6%+18.2%6.9%
STAASTAAR Surgical CompanyLTM Apr 2026$4.14M USD-28.1%+23.3%1.4%
SGPSpyGlass Pharma, Inc. Common StockFY2025$3.11M USD———
SGHTSight Sciences, Inc.LTM Mar 2026$1.86M USD——2.3%
OCSOculis Holding AGLTM Mar 2026CHF 1.76M CHF-15.4%+137.6%349.0%
ALCAlcon Inc.LTM Sep 2026$0 USD-100.0%+64.8%0.0%
Peer median (excluding SGP) —-15.5%+65.0%2.3%

Competitors are the stored peer set for SGP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Intrinsic Alpha fair value

Locked

Current Price

$29.68

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.